Bank Of Montreal Spectrum Pharmaceuticals Inc Transaction History

Bank Of Montreal

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$0.63 - $1.59 $29,890 - $75,437	-47,445 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$1.27 - $2.42 $9,361 - $17,837	-7,371 Reduced 13.45%	47,445 $65,000
Q3 2021 Nov 12, 2021	BUY	$2.15 - $3.82 $10,274 - $18,255	4,779 Added 9.55%	54,816 $123,000
Q2 2021 Aug 12, 2021	BUY	$2.89 - $4.45 $144,606 - $222,664	50,037 New	50,037 $197,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.